Cleared Abbreviated

K003499 - REMVIEW SLEEP RECORDER, MODEL 320

K003499 is an FDA 510(k) clearance for REMVIEW SLEEP RECORDER, manufactured by Respironics, Inc.. The device is a Class 2 Neurology device with product code LEL cleared through the Abbreviated 510(k) pathway after a 88-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2001
Decision
88d
Days
Class 2
Risk

K003499 is an FDA 510(k) clearance for the REMVIEW SLEEP RECORDER, MODEL 320. Classified as Device, Sleep Assessment (product code LEL), Class II - Special Controls.

Submitted by Respironics, Inc. (Murrysville, US). The FDA issued a Cleared decision on February 9, 2001 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Respironics, Inc. devices

FDA 510(k) Submission Details - K003499

510(k) Number K003499 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2000
Decision Date February 09, 2001
Days to Decision 88 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 148d · This submission: 88d
Pathway characteristics
Standards-based clearance path.

LEL Device Classification - Class 2, Special Controls

Product Code LEL Device, Sleep Assessment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LEL Device, Sleep Assessment

All 15
Devices cleared under the same product code (LEL) and FDA review panel - the closest regulatory comparables to K003499.
SBV2, MULTICHARGER MODEL MC10V2
K111514 · Sleep Performance D.B.A. Fatigue Science · Dec 2011
EASYNET BODY POSITION MODULE
K040932 · Cadwell Laboratories, Inc. · Jul 2004
CADWELL LIMB MOVEMENT MODULE
K040986 · Cadwell Laboratories, Inc. · Jul 2004
ULTIMA BODY POSITION SENSOR
K981969 · Braebon Medical Corp. · Aug 1998
B SMART MODEL 1
K961817 · Koven Technology, Inc. · Jul 1997
SOMNITOR 32K SLEEP ACTIVITY MONITOR
K965079 · Neurim Pharmaceuticals, Ltd. · Jul 1997